Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

An acenocoumarol dosing algorithm using clinical and pharmacogenetic data in Spanish patients with thromboembolic disease.

Borobia AM, Lubomirov R, Ramírez E, Lorenzo A, Campos A, Muñoz-Romo R, Fernández-Capitán C, Frías J, Carcas AJ.

PLoS One. 2012;7(7):e41360. doi: 10.1371/journal.pone.0041360. Epub 2012 Jul 20.

2.

Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial.

Carcas AJ, Borobia AM, Velasco M, Abad-Santos F, Díaz MQ, Fernández-Capitán C, Ruiz-Giménez N, Madridano O, Sillero PL; PGX-ACE Spanish Investigators Group.

Trials. 2012 Dec 13;13:239. doi: 10.1186/1745-6215-13-239.

3.

Prediction of stable acenocoumarol dose by a pharmacogenetic algorithm.

Jiménez-Varo E, Cañadas-Garre M, Gutiérrez-Pimentel MJ, Calleja-Hernández MA.

Pharmacogenet Genomics. 2014 Oct;24(10):501-13. doi: 10.1097/FPC.0000000000000082.

PMID:
25089947
4.

Acenocoumarol Pharmacogenetic Dosing Algorithms and Their Application in Two Bulgarian Patients with Low Anticoagulant Requirements.

Dimitrova-Karamfilova A, Tzveova R, Chilingirova N, Goranova T, Nachev G, Mitev V, Kaneva R.

Biochem Genet. 2015 Dec;53(11-12):334-50. doi: 10.1007/s10528-015-9695-8. Epub 2015 Sep 16.

PMID:
26377995
5.

A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population.

Tong HY, Dávila-Fajardo CL, Borobia AM, Martínez-González LJ, Lubomirov R, Perea León LM, Blanco Bañares MJ, Díaz-Villamarín X, Fernández-Capitán C, Cabeza Barrera J, Carcas AJ; PGX-ACE Investigators Group.

PLoS One. 2016 Mar 15;11(3):e0150456. doi: 10.1371/journal.pone.0150456. eCollection 2016.

6.

Impact of genetic and clinical factors on dose requirements and quality of anticoagulation therapy in Polish patients receiving acenocoumarol: dosing calculation algorithm.

Wolkanin-Bartnik J, Pogorzelska H, Szperl M, Bartnik A, Koziarek J, Bilinska ZT.

Pharmacogenet Genomics. 2013 Nov;23(11):611-8. doi: 10.1097/FPC.0000000000000004.

PMID:
24108193
7.

Therapeutic dosing of acenocoumarol: proposal of a population specific pharmacogenetic dosing algorithm and its validation in north Indians.

Rathore SS, Agarwal SK, Pande S, Singh SK, Mittal T, Mittal B.

PLoS One. 2012;7(5):e37844. doi: 10.1371/journal.pone.0037844. Epub 2012 May 22.

8.

The pediatric acenocoumarol dosing algorithm: the Children Anticoagulation and Pharmacogenetics Study.

Maagdenberg H, Bierings MB, van Ommen CH, van der Meer FJM, Appel IM, Tamminga RYJ, le Cessie S, Swen JJ, van der Straaten T, de Boer A, Maitland-van der Zee AH.

J Thromb Haemost. 2018 Sep;16(9):1732-1742. doi: 10.1111/jth.14211. Epub 2018 Jul 17.

PMID:
29935043
9.

Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon.

Verhoef TI, Redekop WK, Daly AK, van Schie RM, de Boer A, Maitland-van der Zee AH.

Br J Clin Pharmacol. 2014 Apr;77(4):626-41. doi: 10.1111/bcp.12220. Review.

10.

Comparative performance of warfarin pharmacogenetic algorithms in Chinese patients.

Liu Y, Yang J, Xu Q, Xu B, Gao L, Zhang Y, Zhang Y, Wang H, Lu C, Zhao Y, Yin T.

Thromb Res. 2012 Sep;130(3):435-40. doi: 10.1016/j.thromres.2012.02.003. Epub 2012 Feb 27.

PMID:
22374335
11.

Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.

Stergiopoulos K, Brown DL.

JAMA Intern Med. 2014 Aug;174(8):1330-8. doi: 10.1001/jamainternmed.2014.2368.

PMID:
24935087
12.

A novel acenocoumarol pharmacogenomic dosing algorithm for the Greek population of EU-PACT trial.

Ragia G, Kolovou V, Kolovou G, Konstantinides S, Maltezos E, Tavridou A, Tziakas D, Maitland-van der Zee AH, Manolopoulos VG.

Pharmacogenomics. 2017 Jan;18(1):23-34. doi: 10.2217/pgs-2016-0126. Epub 2016 Dec 14.

PMID:
27967328
13.

Improved accuracy of anticoagulant dose prediction using a pharmacogenetic and artificial neural network-based method.

Isma'eel HA, Sakr GE, Habib RH, Almedawar MM, Zgheib NK, Elhajj IH.

Eur J Clin Pharmacol. 2014 Mar;70(3):265-73. doi: 10.1007/s00228-013-1617-2. Epub 2013 Dec 3.

PMID:
24297344
14.

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data.

van Schie RM, Wessels JA, le Cessie S, de Boer A, Schalekamp T, van der Meer FJ, Verhoef TI, van Meegen E, Rosendaal FR, Maitland-van der Zee AH; EU-PACT Study Group.

Eur Heart J. 2011 Aug;32(15):1909-17. doi: 10.1093/eurheartj/ehr116. Epub 2011 Jun 2. Erratum in: Eur Heart J. 2013 Jun;34(24):1854.

PMID:
21636598
15.

A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.

Verhoef TI, Ragia G, de Boer A, Barallon R, Kolovou G, Kolovou V, Konstantinides S, Le Cessie S, Maltezos E, van der Meer FJ, Redekop WK, Remkes M, Rosendaal FR, van Schie RM, Tavridou A, Tziakas D, Wadelius M, Manolopoulos VG, Maitland-van der Zee AH; EU-PACT Group.

N Engl J Med. 2013 Dec 12;369(24):2304-12. doi: 10.1056/NEJMoa1311388. Epub 2013 Nov 19.

16.

Extrapolation of acenocoumarol pharmacogenetic algorithms.

Jiménez-Varo E, Cañadas-Garre M, Garcés-Robles V, Gutiérrez-Pimentel MJ, Calleja-Hernández MÁ.

Vascul Pharmacol. 2015 Nov;74:151-157. doi: 10.1016/j.vph.2015.06.010. Epub 2015 Jun 27.

PMID:
26122664
17.

Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin.

Schwartz JB, Kane L, Moore K, Wu AH.

J Am Med Dir Assoc. 2011 Nov;12(9):633-8. doi: 10.1016/j.jamda.2010.12.006. Epub 2011 Jan 26.

PMID:
21450231
18.

Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands.

Zhang Y, de Boer A, Verhoef TI, van der Meer FJ, Le Cessie S, Maitland-van der Zee AH; EU-PACT group; members of the EU-PACT group are.

Thromb Res. 2015 Jul;136(1):94-100. doi: 10.1016/j.thromres.2015.04.034. Epub 2015 May 2.

PMID:
25971661
19.

Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials.

Tang T, Liu J, Zuo K, Cheng J, Chen L, Lu C, Han S, Xu J, Jia Z, Ye M, Pei E, Zhang X, Li M.

J Cardiovasc Pharmacol Ther. 2015 Jul;20(4):387-94. doi: 10.1177/1074248414565666. Epub 2015 Jan 8.

PMID:
25575537
20.

The COAG and EU-PACT trials: what is the clinical benefit of pharmacogenetic-guided coumarin dosing during therapy initiation?

Baranova EV, Asselbergs FW, de Boer A, Maitland-van der Zee AH.

Curr Mol Med. 2014;14(7):841-8. Review.

PMID:
25109798

Supplemental Content

Support Center